002099 Share Price Performance
CN¥5.68
-1.18 (-17.20%)
Price CN¥5.68
Share PriceCN¥5.68
Is Zhejiang Hisoar Pharmaceutical (SZSE:002099) Using Debt In A Risky Way?
Jan 05
Zhejiang Hisoar Pharmaceutical Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
002099 Community Narratives
There are no narratives available yet.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 29, 2025
- Earnings per share (EPS)
- -0.22
- Gross Margin
- 17.76%
- Net Profit Margin
- -19.41%
- Debt/Equity Ratio
- 30.8%
Zhejiang Hisoar Pharmaceutical Co., Ltd. Competitors
Snowflake Analysis
About 002099
- Founded
- 1966
- Employees
- 2611
- CEO
- WebsiteView website
Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical chemical supplies and appliances, other chemical intermediates. The company was founded in 1966 and is based in Taizhou, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 1.8%
- 3 Months: 18.3%
- 1 Year: 24.1%
- Year to Date: 26.2%
The Industrials sector has led the market, which has gained 1.8%. As for the past 12 months, the market is up 24%. As for the next few years, earnings are expected to grow by 27% per annum. Market details ›